Curis, Inc. (CRIS)
0.9065
+0.06
(+6.65%)
USD |
NASDAQ |
Nov 06, 16:00
0.8013
-0.11
(-11.61%)
After-Hours: 20:00
Curis Enterprise Value : -2.806M for Nov. 6, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 06, 2026 | -2.806M |
| November 05, 2026 | -2.916M |
| November 04, 2026 | -2.410M |
| November 03, 2026 | -3.182M |
| November 02, 2026 | -3.285M |
| October 30, 2026 | -3.404M |
| October 29, 2026 | -3.504M |
| October 28, 2026 | -3.688M |
| October 27, 2026 | -3.788M |
| October 26, 2026 | -3.838M |
| October 23, 2026 | -3.820M |
| October 22, 2026 | -3.784M |
| October 21, 2026 | -3.809M |
| October 20, 2026 | -3.794M |
| October 19, 2026 | -3.829M |
| October 16, 2026 | -3.780M |
| October 15, 2026 | -3.583M |
| October 14, 2026 | -3.404M |
| October 13, 2026 | -3.374M |
| October 12, 2026 | -3.319M |
| October 09, 2026 | -3.265M |
| October 08, 2026 | -3.190M |
| October 07, 2026 | -3.137M |
| October 06, 2026 | -3.113M |
| October 05, 2026 | -3.035M |
| Date | Value |
|---|---|
| October 02, 2026 | -3.007M |
| October 01, 2026 | -2.954M |
| September 30, 2026 | -2.938M |
| September 29, 2026 | -2.957M |
| September 28, 2026 | -2.953M |
| September 25, 2026 | -2.956M |
| September 24, 2026 | -2.859M |
| September 23, 2026 | -2.718M |
| September 22, 2026 | -2.624M |
| September 21, 2026 | -2.674M |
| September 18, 2026 | -2.624M |
| September 17, 2026 | -2.449M |
| September 16, 2026 | -2.390M |
| September 15, 2026 | -2.371M |
| September 14, 2026 | -2.390M |
| September 11, 2026 | -2.371M |
| September 10, 2026 | -2.312M |
| September 09, 2026 | -2.234M |
| September 08, 2026 | -2.098M |
| September 04, 2026 | -1.942M |
| September 03, 2026 | -1.903M |
| September 02, 2026 | -1.883M |
| September 01, 2026 | -1.805M |
| August 31, 2026 | -1.669M |
| August 28, 2026 | -1.669M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Agenus, Inc. | 506.92M |
| Amgen, Inc. | 289.86B |
| Anika Therapeutics, Inc. | 176.07M |
| BioCryst Pharmaceuticals, Inc. | 2.422B |
| Imunon, Inc. | 4.922M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -8.581M |
| Total Expenses (Quarterly) | 8.581M |
| EPS Diluted (Quarterly) | -4.017 |
| Earnings Yield | -1.58K% |
| Normalized Earnings Yield | -3272.01 |